Search Results - "Parolia, Abhijit"
-
1
Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer
Published in Nature (London) (01-07-2019)“…Abtract Forkhead box A1 (FOXA1) is a pioneer transcription factor that is essential for the normal development of several endoderm-derived organs, including…”
Get full text
Journal Article -
2
Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer
Published in Nature (London) (20-01-2022)“…The switch/sucrose non-fermentable (SWI/SNF) complex has a crucial role in chromatin remodelling 1 and is altered in over 20% of cancers 2 , 3 . Here we…”
Get full text
Journal Article -
3
The non-coding transcriptome as a dynamic regulator of cancer metastasis
Published in Cancer and metastasis reviews (01-03-2014)“…Since the discovery of microRNAs, non-coding RNAs (NC-RNAs) have increasingly attracted the attention of cancer investigators. Two classes of NC-RNAs are…”
Get full text
Journal Article -
4
Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas
Published in Science translational medicine (23-11-2016)“…Childhood posterior fossa (PF) ependymomas cause substantial morbidity and mortality. These tumors lack recurrent genetic mutations, but a subset of these…”
Get more information
Journal Article -
5
Distinct mutational processes shape selection of MHC class I and class II mutations across primary and metastatic tumors
Published in Cell reports (Cambridge) (29-08-2023)“…Disruption of antigen presentation via loss of major histocompatibility complex (MHC) expression is a strategy whereby cancer cells escape immune surveillance…”
Get full text
Journal Article -
6
Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer
Published in Oncotarget (15-02-2014)“…Metastatic prostate cancer (PCa) is still an incurable disease. Long non-coding RNAs (lncRNAs) may be an overlooked source of cancer biomarkers and therapeutic…”
Get full text
Journal Article -
7
miR-100-5p inhibition induces apoptosis in dormant prostate cancer cells and prevents the emergence of castration-resistant prostate cancer
Published in Scientific reports (22-06-2017)“…Carcinoma of the prostate is the most common cancer in men. Treatment of aggressive prostate cancer involves a regiment of radical prostectomy, radiation…”
Get full text
Journal Article -
8
PIKfyve, expressed by CD11c-positive cells, controls tumor immunity
Published in Nature communications (28-06-2024)“…Cancer treatment continues to shift from utilizing traditional therapies to targeted ones, such as protein kinase inhibitors and immunotherapy. Mobilizing…”
Get full text
Journal Article -
9
The long non-coding RNA PCGEM1 is regulated by androgen receptor activity in vivo
Published in Molecular cancer (21-02-2015)“…Long non-coding RNAs (lncRNAs) can orchestrate oncogenic or tumor-suppressive functions in cancer biology. Accordingly, PCGEM1 and PRNCR1 were implicated in…”
Get full text
Journal Article -
10
The long noncoding RNA HORAS5 mediates castration‐resistant prostate cancer survival by activating the androgen receptor transcriptional program
Published in Molecular oncology (01-05-2019)“…Prostate cancer (PCa) is driven by the androgen receptor (AR)‐signaling axis. Hormonal therapy often mitigates PCa progression, but a notable number of cases…”
Get full text
Journal Article -
11
The evolutionarily conserved long non‐coding RNA LINC00261 drives neuroendocrine prostate cancer proliferation and metastasis via distinct nuclear and cytoplasmic mechanisms
Published in Molecular oncology (01-07-2021)“…Metastatic neuroendocrine prostate cancer (NEPC) is a highly aggressive disease, whose incidence is rising. Long noncoding RNAs (lncRNAs) represent a large…”
Get full text
Journal Article -
12
Integrated analysis of the prostate cancer small-nucleolar transcriptome reveals SNORA55 as a driver of prostate cancer progression
Published in Molecular oncology (01-05-2016)“…Metastasis is the primary cause of death in prostate cancer (PCa) patients. Small nucleolar RNAs (snoRNAs) have long been considered “housekeeping” genes with…”
Get full text
Journal Article -
13
Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancer
Published in Clinical epigenetics (12-02-2016)“…While localized prostate cancer (PCa) can be effectively cured, metastatic disease inevitably progresses to a lethal state called castration-resistant prostate…”
Get full text
Journal Article -
14
-
15
Non-invasive metabolic imaging of brain tumours in the era of precision medicine
Published in Nature reviews. Clinical oncology (01-12-2016)“…Key Points Brain tumours, such as gliomas, in adults and children are morphologically similar, but harbour different genomic alterations, both across and…”
Get full text
Journal Article -
16
Abstract 4420: Polytect, a robust algorithm to detect somatic mutations in polymorphic MHC/HLA genes
Published in Cancer research (Chicago, Ill.) (15-08-2020)“…Abstract Background: The immune system is able to recognize tumor cells through the presentation of mutant peptides via the major histocompatibility complex…”
Get full text
Journal Article -
17
Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2
Published in Proceedings of the National Academy of Sciences - PNAS (05-01-2021)“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for COVID-19, employs two key host proteins to gain entry and replicate…”
Get full text
Journal Article -
18
Abstract 3347: Exploring the role of ASXL family of genes in enabling oncogenic AR-signaling in prostate cancer
Published in Cancer research (Chicago, Ill.) (01-07-2017)“…Abstract Prostate cancer (PCa) is the second leading cause of cancer-related mortality in North American men. In recent years, there has been mounting evidence…”
Get full text
Journal Article -
19
Competing for enhancers: PVT1 fine-tunes MYC expression
Published in Cell research (01-08-2018)Get full text
Journal Article -
20
Discovery of LLC0424 as a Potent and Selective in Vivo NSD2 PROTAC Degrader
Published in Journal of medicinal chemistry (09-05-2024)“…Nuclear receptor-binding SET domain-containing 2 (NSD2), a methyltransferase that primarily installs the dimethyl mark on lysine 36 of histone 3 (H3K36me2),…”
Get full text
Journal Article